object
retrospect
analyz
clinic
data
corona
viru
diseas
patient
explor
valu
serum
phosphoru
level
evalu
sever
prognosi
diseas
method
patient
transfer
first
emerg
ward
taiyuan
fourth
peopl
hospit
februari
march
enrol
inform
gener
condit
clinic
manifest
laboratori
index
nucleic
acid
detect
treatment
collect
chang
blood
phosphoru
level
absolut
valu
lymphocyt
ordinari
severecrit
patient
record
compar
result
total
patient
collect
includ
case
common
type
case
severecrit
type
treatment
serum
phosphoru
level
two
group
significantli
lower
normal
level
serum
phosphoru
level
severecrit
patient
lower
common
type
patient
p
treatment
serum
phosphoru
level
two
group
reach
normal
signific
differ
two
group
p
level
lymphocyt
severecrit
patient
lower
normal
patient
p
treatment
treatment
absolut
valu
lymphocyt
two
group
reach
normal
signific
differ
two
group
posit
correl
lymphocyt
serum
phosphoru
correl
coeffici
conclus
hypophosphatemia
relat
sever
strengthen
monitor
serum
phosphoru
level
severecrit
patient
correct
hypophosphatemia
time
signific
improv
prognosi
latest
threat
global
public
health
ongo
outbreak
coronaviru
diseas
covid
march
nearli
thousand
case
confirm
countri
region
around
world
phosphoru
one
essenti
major
element
human
bodi
play
import
role
phospholipid
bilay
make
cell
membran
bodi
particip
synthesi
energi
metabol
adenosin
triphosph
atp
regul
enzymat
reaction
form
buffer
system
maintain
acidbas
balanc
bodi
sinc
outbreak
epidem
situat
blood
phosphoru
severecrit
ill
patient
report
purpos
studi
explor
correl
hypophosphatemia
sever
patient
analyz
level
chang
serum
phosphoru
sever
critic
ill
patient
studi
enrol
patient
fourth
peopl
taiyuan
citi
februari
march
met
diagnosi
treatment
novel
coronaviru
pneumonia
trial
version
fifth
inform
consent
obtain
individu
particip
studi
approv
taiyuan
forth
peopl
hospit
ethic
committe
accord
novel
coronaviru
pneumonia
treatment
plan
trial
version
fifth
clinic
classif
light
mild
clinic
symptom
pneumonia
imag
common
fever
respiratori
tract
imag
find
pneumonia
heavi
follow
follow
respiratori
distress
respiratori
timemin
rest
state
oxygen
satur
arteri
partial
pressur
oxygen
concentr
oxygen
mm
hg
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
mm
hg
kpa
sever
one
follow
condit
met
respiratori
failur
occur
mechan
ventil
requir
shock
occur
organ
failur
need
icu
monitor
treatment
automat
biochem
analyz
siemen
compani
germani
use
determin
blood
phosphoru
ultraviolet
end
point
colorimetri
phosphomolybd
refer
valu
rang
blood
phosphoru
blood
phosphoru
defin
hypophosphatemia
origin
match
detect
reagent
mindray
automat
hematolog
analyz
use
analysi
determin
blood
cell
five
classif
refer
rang
normal
valu
lymphocyt
l
lymphocyt
l
defin
low
lymphocyt
patient
diagnos
includ
case
common
type
case
sever
critic
type
gener
data
patient
collect
accord
case
system
includ
sex
age
epidemiolog
histori
incid
clinic
manifest
laboratori
examin
includ
nucleic
acid
test
imag
examin
treatment
outcom
etc
chang
serum
phosphoru
level
absolut
valu
lymphocyt
two
group
record
compar
mean
standard
deviat
use
statist
descript
quantit
data
test
two
independ
sampl
use
statist
analysi
qualit
data
describ
use
rate
composit
ratio
chi
squar
test
use
statist
analysi
pearson
correl
coeffici
use
analyz
correl
index
statist
signific
set
total
patient
collect
studi
averag
age
severecrit
patient
year
old
ordinari
patient
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
year
old
term
gender
composit
male
ratio
severecrit
patient
male
ratio
common
patient
mean
bodi
mass
index
bmi
severecrit
patient
ordinari
patient
statist
signific
compar
gener
demograph
data
two
group
see
tabl
detail
clinic
manifest
two
group
sever
critic
patient
fever
patient
dyspnea
ordinari
group
patient
fever
case
dyspnea
see
tabl
detail
treatment
serum
phosphoru
level
sever
critic
patient
l
common
patient
level
serum
phosphoru
sever
critic
patient
lower
ordinari
patient
p
treatment
serum
phosphoru
level
two
group
normal
signific
differ
two
group
p
shown
tabl
tabl
level
serum
phosphoru
treatment
two
group
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
tabl
posit
correl
absolut
valu
lymphocyt
level
serum
phosphoru
correl
coeffici
p
indic
strong
correl
two
index
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
phosphoru
import
element
bodi
particip
synthesi
energi
metabol
adenosin
triphosph
atp
content
total
phosphoru
adult
concentr
blood
phosphoru
clinic
incid
hypophosphatemia
studi
found
incid
hypophosphatemia
critic
ill
patient
high
studi
serum
phosphoru
level
lower
normal
severecrit
patient
level
serum
phosphoru
sever
critic
patient
lower
normal
patient
may
due
decreas
level
glycerol
erythrocyt
condit
hypophosphatemia
lead
left
shift
oxygen
dissoci
curv
decreas
oxygen
releas
disord
oxid
phosphoryl
process
final
lead
tissu
hypoxia
due
decreas
atp
energi
suppli
time
disturb
lung
water
absorpt
close
relat
metabol
disord
phosphoru
lack
phosphoru
aggrav
inflammatori
level
lung
tissu
ratio
ventil
blood
flow
edemat
lung
tissu
maladjust
oxygen
function
decreas
induc
fatigu
caus
hypoxia
intercost
muscl
diaphragm
time
product
pulmonari
surfact
reduc
pulmonari
alveoli
trap
respiratori
failur
aggrav
studi
confirm
time
correct
hypophosphatemia
patient
hypophosphatemia
revers
symptom
improv
prognosi
level
serum
phosphoru
relat
sever
elderli
patient
ventilatorassoci
pneumonia
vap
predict
valu
prognosi
elderli
patient
vap
therefor
sever
damag
immun
function
lead
hypophosphatemia
turn
aggrav
progress
diseas
data
report
hubei
provinc
suggest
total
number
leukocyt
peripher
blood
patient
normal
decreas
lymphocyt
count
decreas
patient
good
prognosi
treatment
seriou
patient
progress
rapidli
peripher
blood
lymphocyt
decreas
progress
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
patholog
anatomi
patient
reveal
patient
lymphocyt
overactiv
highli
proinflammatori
cell
increas
partial
explain
sever
immun
damag
lung
neocoronari
pneumonia
studi
patient
severecrit
type
lymphocyt
absolut
valu
lower
refer
rang
lymphocyt
level
patient
severecrit
type
lower
patient
normal
patient
studi
shown
immun
function
elderli
patient
sever
pneumonia
significantli
lower
healthi
peer
immun
function
patient
hypophosphatemia
lower
gener
state
immunosuppress
studi
found
serum
phosphoru
elderli
patient
sever
pneumonia
posit
correl
ratio
studi
also
show
posit
correl
absolut
valu
lymphocyt
level
serum
phosphoru
time
treatment
phosphoru
supplement
sever
patient
low
phosphoru
may
improv
immun
level
promot
recoveri
decreas
blood
phosphoru
level
clinic
practic
commonli
seen
chronic
diseas
fast
malnutrit
parenter
nutrit
metabol
respiratori
alkalosi
diabet
ketoacidosi
alcohol
chronic
alcohol
withdraw
inadequ
phosphoru
intak
without
time
supplement
severecrit
patient
mention
studi
middleag
overweight
bmi
underli
diseas
decreas
blood
phosphoru
level
detect
day
admiss
like
novel
coronaviru
invad
human
bodi
caus
strong
stress
respons
releas
inflammatori
factor
one
hand
gastrointestin
function
declin
gastrointestin
mucos
cell
integr
barrier
function
impair
result
reduct
phosphoru
intak
food
hand
stress
respons
lead
increas
secret
epinephrin
glucagon
etc
sever
reduc
util
intracellular
phosphoru
lead
migrat
larg
amount
phosphoru
cell
particip
energi
metabol
addit
follow
treatment
trial
version
fifth
also
treat
patient
hypophosphatemia
phosphoru
supplement
recoveri
diseas
transform
viral
nucleic
acid
blood
phosphoru
level
absolut
valu
lymphocyt
major
severecrit
patient
return
normal
process
caus
exogen
supplement
redistribut
phosphoru
insid
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
outsid
cell
gradual
recoveri
immun
system
scientif
basic
clinic
research
need
futur
studi
patient
met
discharg
standard
current
treatment
scheme
trial
version
fifth
still
four
patient
absolut
valu
lymphocyt
two
patient
blood
phosphoru
level
return
normal
patient
viral
nucleic
acid
convers
posit
discharg
urgent
need
clinic
research
follow
patient
summari
hypophosphatemia
associ
sever
signific
improv
prognosi
strengthen
monitor
blood
phosphoru
level
patient
severecrit
type
correct
hypophosphatemia
time
limit
studi
first
emerg
ward
taiyuan
fourth
peopl
hospit
ward
treatment
severecrit
covid
patient
shanxi
provinc
small
number
sampl
may
affect
statist
analysi
result
face
sudden
outbreak
lifethreaten
diseas
one
use
placebo
control
make
sens
exogen
phosphoru
supplement
